Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

Recognizing skin symptoms in children can help diagnose and manage serious diseases early.

EPDS can cause recurring scalp sores and hair loss if not treated.

The conclusion is that Erosive Pustular Dermatosis of the Scalp is a rare condition best treated with strong topical steroids and sometimes systemic treatment.

COVID-19 infection can cause new hair loss conditions or worsen existing skin diseases, with hair loss being the most common issue.

A woman with a scalp infection and herpes recovered fully after treatment.

People with Epidermolysis bullosa have many health problems including poor oral health, which is often neglected due to other medical issues.

Neuropathic pruritus is a commonly overlooked and wrongly diagnosed type of chronic itching that is hard to treat.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

A woman's shingles infection triggered her first episode of a rare neurological disorder and blood vessel inflammation.

Hair gels may cause split ends in children.

Most kidney transplant patients in the study had skin problems, often related to infections, medication side effects, or skin cancer risks.

Most pediatric inpatients needed dermatology consultations for unspecified rashes and drug reactions, with varied treatments.

Proper care and understanding of skin diseases in pregnant women are crucial for their health and recovery.

Daily use of antifungal shampoo can hide symptoms and make it hard to diagnose fungal scalp infections.

Young adults who had liver disease as children often experience significant health problems and frequently need transplants.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.